Silinskaite Ugne, Valciukiene Jurate, Jakubauskas Matas, Poskus Tomas
Institute of Translational Health Research, Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania.
Biomedicines. 2025 Mar 12;13(3):699. doi: 10.3390/biomedicines13030699.
Research on colorectal adenoma is significantly less comprehensive compared to studies on colorectal carcinoma. Although colorectal adenoma is a precursor of the majority of sporadic colorectal cancers, not all adenomas develop into carcinomas. The complex interaction of immune responses in the premalignant tumor microenvironment might be a factor for that. In this systematic review, we aim to provide a thorough analysis of the current research examining the immune infiltration patterns in sporadic colorectal adenoma tissues in the context of immune cell-based, cytokine-based, and other immunological factor-related changes along the conventional adenoma-carcinoma sequence. The articles included in the review extend up to December 2024 in PubMed and Web of Science databases. Most included studies have shown significant differences in immune cell counts, densities, and cytokine expression levels associated with premalignant colorectal lesions (and/or colorectal cancer). No consensus on the immune-related tendencies concerning CD4+T cells and CD8+T cells was reached. Decreasing expression of mDCs and plasma and naïve B cells were detected along the ACS. The increased density of tissue eosinophils in the adenoma tissue dramatically diminishes after the transition to carcinoma. As the adenoma progresses, the increasing expression of IL-1α, IL-4, IL-6, IL-8, IL-10, IL-17A, IL-21, IL-23, IL-33, and TGF-β and decreasing levels of IL-12A, IL-18, IFN-γ, and TNFα cytokines in the invasive carcinoma stage is being detected. The over-expression of COX-2, PD-1/PD-L1, CTLA-4, and ICOS/ICOSLG in the colorectal adenomatous and cancerous tissues was also observed. Further studies are needed for a better understanding of the whole picture of colorectal adenoma-associated immunity and its impact on precancerous lesion's potential to progress.
与结直肠癌的研究相比,对结直肠腺瘤的研究明显不够全面。尽管结直肠腺瘤是大多数散发性结直肠癌的前体,但并非所有腺瘤都会发展成癌。癌前肿瘤微环境中免疫反应的复杂相互作用可能是一个因素。在本系统评价中,我们旨在全面分析当前研究,这些研究在基于免疫细胞、基于细胞因子以及其他免疫相关因子变化的背景下,沿着传统的腺瘤 - 癌序列,研究散发性结直肠腺瘤组织中的免疫浸润模式。纳入本评价的文章截至2024年12月在PubMed和Web of Science数据库中的文献。大多数纳入研究表明,与癌前结直肠病变(和/或结直肠癌)相关的免疫细胞计数、密度和细胞因子表达水平存在显著差异。关于CD4 + T细胞和CD8 + T细胞的免疫相关趋势尚未达成共识。沿着腺瘤 - 癌序列检测到成熟树突状细胞、浆细胞和幼稚B细胞的表达降低。腺瘤组织中组织嗜酸性粒细胞密度在转变为癌后显著降低。随着腺瘤进展,在浸润性癌阶段检测到IL - 1α、IL - 4、IL - 6、IL - 8、IL - 10、IL - 17A、IL - 21、IL - 23、IL - 33和TGF - β表达增加,而IL - 12A、IL - 18、IFN - γ和TNFα细胞因子水平降低。在结直肠腺瘤和癌组织中还观察到COX - 2、PD - 1/PD - L1、CTLA - 4和ICOS/ICOSLG的过表达。需要进一步研究以更好地了解结直肠腺瘤相关免疫的全貌及其对癌前病变进展潜力的影响。